Iran, Islamic Republic of vs Pakistan: Deaths from Alzheimer's
Iran, Islamic Republic of
11,226 deaths
in 2021
Pakistan
13,329 deaths
in 2021
Iran, Islamic Republic of rank
23rd
Pakistan rank
20th
Deaths from Alzheimer's over time
- Iran, Islamic Republic of
- Pakistan
How they compare
Pakistan currently reports 13,329 deaths against 11,226 deaths in Iran, Islamic Republic of, a difference of 2,103 deaths.
That makes Pakistan's figure about 1.2 times Iran, Islamic Republic of's.
Across all 22 years both countries report, Pakistan has been ahead every year.
Iran, Islamic Republic of ranks 23rd and Pakistan ranks 20th of 194 countries.
Pakistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5,099 deaths | 8,165 deaths | 3,066 deaths | Pakistan |
| 2010s | 8,162 deaths | 10,920 deaths | 2,758 deaths | Pakistan |
| 2020s | 11,522 deaths | 13,348 deaths | 1,826 deaths | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from alzheimer's, Iran, Islamic Republic of or Pakistan?
- Pakistan, at 13,329 deaths against 11,226 deaths in Iran, Islamic Republic of as of 2021.
- What is the difference in deaths from alzheimer's between Iran, Islamic Republic of and Pakistan?
- 2,103 deaths, with Pakistan ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Pakistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Iran, Islamic Republic of and Pakistan rank globally for deaths from alzheimer's?
- Iran, Islamic Republic of ranks 23rd and Pakistan ranks 20th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes.